Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer
- 1 December 2016
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 2 (12) , 1624-1627
Abstract
This Danish nationwide cohort study evaluates the treatment-specific risks for second malignant neoplasms and death in patients with testicular germ cell cancerKeywords
This publication has 13 references indexed in Scilit:
- Germ Cell Cancer and Multiple Relapses: Toxicity and SurvivalJournal of Clinical Oncology, 2015
- Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based StudyJournal of Clinical Oncology, 2015
- Solid Tumors After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based StudyJournal of Clinical Oncology, 2013
- Adverse Prognostic Factors for Testicular Cancer–Specific Survival: A Population-Based Study of 27,948 PatientsJournal of Clinical Oncology, 2011
- Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular CancerJournal of Clinical Oncology, 2007
- Noncancer Causes of Death in Survivors of Testicular CancerJNCI: Journal of the National Cancer Institute, 2007
- Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term SurvivorsJNCI: Journal of the National Cancer Institute, 2005
- Increased mortality rates in young and middle-aged patients with malignant germ cell tumoursBritish Journal of Cancer, 2004
- Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular CancerJournal of Clinical Oncology, 2000
- Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patientsEuropean Journal of Cancer, 1997